PetMed Express (PETS) to Release Earnings on Monday

PetMed Express (NASDAQ:PETS) is anticipated to post its Q3 2026 results before the market opens on Monday, February 9th. Analysts expect the company to announce earnings of ($0.06) per share for the quarter. Investors may review the information on the company’s upcoming Q3 2026 earning report for the latest details on the call scheduled for Monday, February 9, 2026 at 4:00 PM ET.

PetMed Express Price Performance

PETS stock opened at $3.19 on Monday. The company has a market capitalization of $68.17 million, a P/E ratio of -1.20 and a beta of 0.70. PetMed Express has a 12 month low of $1.57 and a 12 month high of $5.58. The firm’s fifty day simple moving average is $2.93 and its 200-day simple moving average is $2.85.

Wall Street Analyst Weigh In

PETS has been the topic of several analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of PetMed Express in a research report on Monday, December 29th. Wall Street Zen downgraded PetMed Express from a “hold” rating to a “sell” rating in a research note on Saturday, October 18th. One equities research analyst has rated the stock with a Hold rating and two have given a Sell rating to the company. According to MarketBeat, PetMed Express has an average rating of “Sell” and a consensus target price of $3.20.

Institutional Trading of PetMed Express

Several institutional investors have recently modified their holdings of PETS. Goldman Sachs Group Inc. lifted its position in shares of PetMed Express by 59.3% in the first quarter. Goldman Sachs Group Inc. now owns 33,209 shares of the company’s stock valued at $139,000 after acquiring an additional 12,360 shares in the last quarter. Occudo Quantitative Strategies LP acquired a new position in shares of PetMed Express in the 2nd quarter worth approximately $51,000. Bridgeway Capital Management LLC raised its holdings in shares of PetMed Express by 96.2% in the 2nd quarter. Bridgeway Capital Management LLC now owns 40,800 shares of the company’s stock valued at $135,000 after buying an additional 20,000 shares during the period. Oxford Asset Management LLP purchased a new stake in PetMed Express during the 2nd quarter worth approximately $55,000. Finally, Dimensional Fund Advisors LP increased its holdings in PetMed Express by 5.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 481,517 shares of the company’s stock worth $1,209,000 after purchasing an additional 24,624 shares during the period. Institutional investors and hedge funds own 73.33% of the company’s stock.

About PetMed Express

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.